ResearcherUniversity of KentuckyActive in the last 2 years
Wei Li
Matched on ORCID iD 0000-0002-0746-1091; OpenAlex author ID A5100318101. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 6
- RRM2 promotes liver metastasis of pancreatic cancer by stabilizing YBX1 and activating the TGF-beta pathway. Co-author DOI 10.1016/j.isci.2024.110864↗
- The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer. Last author DOI 10.1038/s41389-018-0102-2↗
- Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresect… Last author DOI 10.18632/oncotarget.21340↗
- FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Last author DOI 10.18632/oncotarget.9975↗
- The Role of Stromal Components in Pancreatic Cancer Progression. Last author DOI 10.2174/1871520616666160404115532↗
- FH535 inhibited metastasis and growth of pancreatic cancer cells. Co-author DOI 10.2147/ott.s82718↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tao Liu · 1 shared paper, 2024 · strength 0.24
- Zhouyuan Du · 1 shared paper, 2024 · strength 0.24
- Haixin Yu · 1 shared paper, 2024 · strength 0.24
- Min Tao · 4 shared papers, 2015–2018 · strength 0.23
- Paper The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic c… DOI 10.1038/s41389-018-0102-2↗
- Paper Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio… DOI 10.18632/oncotarget.21340↗
- Paper FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. DOI 10.18632/oncotarget.9975↗
- Qiaoming Zhi · 3 shared papers, 2016–2018 · strength 0.19
- Paper The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic c… DOI 10.1038/s41389-018-0102-2↗
- Paper Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio… DOI 10.18632/oncotarget.21340↗
- Paper FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. DOI 10.18632/oncotarget.9975↗
- Mengyao Wu · 3 shared papers, 2015–2018 · strength 0.18
- Paper The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic c… DOI 10.1038/s41389-018-0102-2↗
- Paper Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio… DOI 10.18632/oncotarget.21340↗
- Paper FH535 inhibited metastasis and growth of pancreatic cancer cells. DOI 10.2147/ott.s82718↗
- Kai Chen · 3 shared papers, 2015–2018 · strength 0.17
- Paper The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic c… DOI 10.1038/s41389-018-0102-2↗
- Paper FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. DOI 10.18632/oncotarget.9975↗
- Paper FH535 inhibited metastasis and growth of pancreatic cancer cells. DOI 10.2147/ott.s82718↗
- Lian Lian · 3 shared papers, 2015–2017 · strength 0.16
- Paper Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio… DOI 10.18632/oncotarget.21340↗
- Paper FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. DOI 10.18632/oncotarget.9975↗
- Paper FH535 inhibited metastasis and growth of pancreatic cancer cells. DOI 10.2147/ott.s82718↗
- Meng Shen · 3 shared papers, 2015–2017 · strength 0.16
- Paper Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio… DOI 10.18632/oncotarget.21340↗
- Paper FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. DOI 10.18632/oncotarget.9975↗
- Paper FH535 inhibited metastasis and growth of pancreatic cancer cells. DOI 10.2147/ott.s82718↗
- Mengdan Xu · 2 shared papers, 2016–2018 · strength 0.15
- Weiming Duan · 2 shared papers, 2015–2016 · strength 0.10
- Xiaojie Bian · 1 shared paper, 2017 · strength 0.06
- Yuan Hong Gao · 1 shared paper, 2017 · strength 0.06
- Lu Liu · 1 shared paper, 2016 · strength 0.05
- Mengyao Wu · 1 shared paper, 2016 · strength 0.05
- Daoming Li · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.